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Abstract
Background: Cardiac surgery is increasingly required in octogenarians. These patients frequently
present atrial fibrillation (AF), a significant factor for stroke and premature death. During the last
decade, AF ablation has become an effective procedure in cardiac surgery. Because the results of
concomitant AF ablation in octogenarians undergoing cardiac surgery are still not clear, we
evaluated the outcome in these patients.
Methods: Among 200 patients undergoing concomitant AF ablation (87% persistent AF), 28
patients were ≥ 80 years (82 ± 2.4 years). The outcome was analysed by prospective follow up after
3, 6, 12 months and annually thereafter. Freedom from AF was calculated according to the Kaplan-
Meier method.
Results: Octogenarians were similar to controls regarding AF duration (48 ± 63.2 versus 63 ± 86.3
months, n.s.) and left atrial diameter (49 ± 6.1 versus 49 ± 8.8 mm, n.s.), but differed in EuroSCORE
(17.3 ± 10.93 versus 7.4 ± 7.31%, p < 0.001), prevalence of paroxysmal AF (25.0 versus 11.0%, p =
0.042) and aortic valve disease (67.8 versus 28.5%, p < 0.001). ICU stay (8 ± 16.9 versus 4 ± 7.2
days, p = 0.027), hospital stay (20 ± 23.9 versus 14 ± 30.8 days, p < 0.05), and 30-d-mortality (14.3
versus 4.6%, p = 0.046) were increased. After 12 ± 6.1 months of follow-up (95% complete), 14
octogenarians (82%) and 101 controls (68%, n.s.) were in sinus rhythm; 59% without antiarrhythmic
drugs in either group (n.s.). Sinus rhythm restoration was associated with improved NYHA
functional class and renormalization of left atrial size. Cumulative freedom from AF demonstrated
no difference between groups. Late mortality was higher in octogenarians (16.7 versus 6.1%, p =
0.065).
Conclusion:  Sinus rhythm restoration rate and functional improvement are satisfactory in
octogenarians undergoing concomitant AF ablation. Hence, despite an increased perioperative risk,
this procedure should be considered even in advanced age.
Background
Because industrialized countries are experiencing an aging
population, the age of patients necessitating cardiac sur-
gery is steadily rising. According to the registry of the Ger-
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man Society for Thoracic and Cardiovascular Surgery,
more than 8.4% of patients undergoing cardiac surgical
procedures in 2005 were older than 80 years, compared to
2.7% ten years ago [1]. It was shown that these high risk
elderly patients derive benefit from coronary revasculari-
zation, aortic as well as mitral valve surgery, and com-
bined procedures [2-4].
Atrial fibrillation (AF), a significant factor for stroke and
premature death, is the most frequent sustained atrial
arrhythmia [5]. Because its incidence increases with age, a
growing number of patients scheduled for valvular or cor-
onary heart surgery, nowadays present AF [6,7]. During
the last decade, surgical AF treatment, initially introduced
as Maze procedure [8,9], has been developed to a less
complex operation by using different technologies for tis-
sue ablation and by focussing the lesion pattern on the left
atrium [7,10,11]. AF ablation has become a frequently
performed concomitant procedure in cardiac surgery with
overall promising results regarding sinus rhythm (SR) res-
toration [7,10].
Because the results of surgical AF treatment in octogenari-
ans are not clear, we evaluated outcome of these patients
undergoing cardiac surgery and concomitant AF ablation.
Methods
Patients
Between January 2003 and February 2006, a total of 200
patients (54.5% male) scheduled for cardiac surgery
underwent concomitant AF ablation. The majority of
patients presented with persistent/continuous AF (n =
174, 87.0%) according to established definitions [12,13].
Out of all, 28 patients aged 80 years and older were sum-
marized as group of octogenarians. According to age (< 80
years versus ≥ 80 years), patients were prospectively stud-
ied. Preoperative, perioperative and follow up data were
entered into an institutional database. Informed consent
regarding the operation and data acquisition was
obtained from all patients. For assessment of periopera-
tive risk, logistic EuroSCORE was determined [14].
Surgical procedures and perioperative treatment
The detailed procedures of the study population are listed
in Table 1. For all procedures, standard normothermic
cardiopulmonary bypass and warm antegrade blood car-
dioplegia were used. All patients underwent endocardial
ablation of the left atrium as described in detail previously
[7]. The left atrial appendage was oversewn only if
thrombi were inside (n = 4).
All patients were anticoagulated with heparin followed by
phenprocoumon with a target INR of 2.0–3.0. After 3
months and stable sinus or atrial driven pacemaker
rhythm in Holter ECG and mechanical atrial function in
echocardiogram anticoagulation was ceased. Patients with
mechanical valve substitutes were kept on phenprocou-
mon permanently (INR of 2.5–3.5 for aortic and 3.0–4.0
for mitral valve prostheses). DC shock cardioversion of
early recurrent AF was performed if patient was sympto-
matic or hemodynamically compromised. Periopera-
tively, either patient's preoperative betablocker was
continued or antiarrhythmic treatment with class III
antiarrhythmic drugs (sotalol or amiodarone) was initi-
ated. The decision was left to the discretion of the surgeon.
After discharge, patient's general physician or cardiologist
managed the anticoagulation and antiarrhythmic therapy.
Table 1: Surgical procedures
Overall (n = 200) % (n) Age < 80 yrs (n = 172) % (n) Age ≥ 80 yrs (n = 28) % (n)
MVP/-R 37.5 (75) 41.3 (71) 14.3 (4)
isolated 57.3 (43) 59.2 (42) 25.0 (1)
+ CABG 28.0 (21) 25.4 (18) 75.0 (3)
+ TVP/R/+ CABG/+ congenital 14.7 (11) 15.5 (11) -
AVR 34.0 (68) 28.5 (49) 67.8 (19)
isolated 58.8 (40) 61.2 (30) 52.6 (10)
+ CABG 11.8 (8) 6.1 (3) 26.3 (5)
+ MVP/-R/+ TVP/-R/+ CABG/+ AAR 29.4 (20) 32.6(16) 21.1 (4)
CABG 28.0 (56) 29.6 (51) 17.8 (5)
isolated 98.2 (55) 98.0 (50) 100 (5)
+ aneurysmectomy 1.8 (1) 2.0 (1) -
other procedures 0.5 (1) 0.6 (1) -
LA reduction plasty 1.5 (3) 1.7 (3) -
reoperation 7.0 (14) 7.6 (13) 3.6 (1)
microwave ablation 53.5 (107) 52.9 (91) 57.1 (16)
radiofrequency ablation 46.5 (93) 47.1 (81) 42.8 (12)
AAR, ascending aortic replacement, AVR, aortic valve replacement; CABG, coronary artery bypass grafting; MVP/-R, mitral valve plasty/
replacement; TVP/R, tricuspid valve plasty/replacement; yrs, yearsJournal of Cardiothoracic Surgery 2008, 3:21 http://www.cardiothoracicsurgery.org/content/3/1/21
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Follow up
Prospective follow up (FU) was performed after 3, 6, 12
months and annually thereafter. Patients were inter-
viewed and underwent clinical examination, electrocardi-
ography, and transthoracic echocardiography (TTE). Only
in 9 patients (4.8%), who were not able to visit the clinic,
interviewing was done by telephone and echocardio-
graphic data were obtained from the referring cardiolo-
gist. Ablation was considered successful if SR was
maintained with no symptomatic or documented epi-
sodes of AF or atrial flutter. Any regular atrial driven
rhythm, including atrial (n = 1), atrioventricular (n = 3),
or atrial triggered ventricular (n = 5) pacing, was regarded
as sinus rhythm (SR).
Echocardiography
Preoperatively, before discharge and at FU, all patients
underwent TTE using the HP Sonos 5500 (Hewlett Pack-
ard, Andover, Massachusetts, USA). LA and LV diameter
were measured using standard techniques. LVEF was
assessed by the Simpson method. For assessment of LA
function the pulsed-wave signal of diastolic transmitral
flow was used. Maximal flow velocities of E and A waves
were measured and E/A ratio was calculated.
Statistical analysis
Unless otherwise indicated, data are presented as mean ±
standard deviation or absolute and relative frequencies.
For comparison between groups, Mann-Whitney's U-test
(continuous variables) and Fisher's exact test (categorical
variables) were used. For comparison of FU and preoper-
ative data within groups Wilcoxon's rank-sum test was
applied. All tests of significance were two-tailed and a
value of p < 0.05 was considered significant. During FU,
freedom from AF was calculated according to the Kaplan-
Meier method. Differences were analysed by log-rank test.
Statistical analysis was performed using a statistical soft-




The mean age of octogenarians was 82 ± 2.4 years (range
80–89 years), whereas the mean age of younger patients
was significantly lower at 68 ± 7.9 years (range 40–79
years). Baseline characteristics are presented in Table 2.
There was a higher proportion of women in octogenarians
which was associated with a lower body surface area. The
pattern of valvular heart disease was significantly different
in both groups with respectively higher incidence of
mitral valve disease in younger and aortic valve disease in
older patients. There was a non-significant trend to an
increased percentage of patients with a history of
thrombembolic events in octogenarians. AF duration and
LA size, two important AF criteria, were similar in either
group, although a higher proportion of younger patients
were in persistent AF. According to New York Heart Asso-
ciation (NYHA) functional class and EuroSCORE, older
patients were significantly more compromised and exhib-
ited a higher perioperative risk.
Procedural outcome
In octogenarians and younger patients, there was no dif-
ference in aortic cross clamp time (90 ± 29.2 and 85 ± 32.0
min, p = 0.464), cardiopulmonary bypass time (125 ±
31.9 and 116 ± 38.5 min, p = 0.568), and operation time
(206 ± 41.0 and 217 ± 60.0 min, p = 0.389). Post ablation
treatment with antiarrhythmic drugs or betablockers was
similar in both groups (Table 3). In 6 patients, a dual
chamber pacemaker was implanted due to sinus node
dysfunction. Regarding perioperative morbidity, the inci-
dence of heart failure requiring intraaortic balloon pump
Table 2: Baseline data
Age < 80 yrs (n = 172) Age ≥ 80 yrs (n = 28) p
male gender % (n) 57.6 (99) 35.7 (10) 0.031
body surface area m2 1.9 ± 0.22 1.8 ± 0.18 0.003
coronary artery disease % (n) 45.3 (78) 50.0 (14) 0.647
mitral valve disease % (n) 50.0 (86) 28.6 (8) 0.035
aortic valve disease % (n) 28.5 (49) 67.8 (19) < 0.001
others % (n) 9.3 (16) - -
previous embolism % (n) 1.7 (3) 7.1 (2) 0.089
persistent AF % (n) 89.0 (153) 75.0 (21) 0.042
AF duration months 63 ± 86.3 48 ± 63.2 0.400
LA diameter mm 49 ± 8.8 49 ± 6.1 0.954
LVEF 0.51 ± 0.013 0.52 ± 0.014 0.656
LVEDD mm 54 ± 8.1 49 ± 10.4 0.379
NYHA class 2.9 ± 0.81 3.4 ± 0.67 0.021
logistic EuroSCORE % 7.4 ± 7.31 17.3 ± 10.93 < 0.001
AF, atrial fibrillation; LA, left atrial; LVEDD, left ventricular enddiastolic diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart 
Association; yrs, yearsJournal of Cardiothoracic Surgery 2008, 3:21 http://www.cardiothoracicsurgery.org/content/3/1/21
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support and the incidence of renal failure was signifi-
cantly higher in octogenarians. All patients of this group
who acquired infections early after operation developed
sepsis. The incidence of cerebral ischemic events was sim-
ilar in younger and older patients. Overall, 2 strokes (on
postoperative day [POD] 1 and 5), and 2 transient neuro-
logical deficits (on POD 2 and 6) occurred. Multiple
thrombembolism due to hereditary thrombotic thrombo-
cytopenic purpura occurred in one of these patients on
POD 5. Apart from a trend to prolonged mechanical ven-
tilation, older age was associated with significantly longer
ICU and hospital stay. Perioperative mortality was higher
in octogenarians. No death was ablation related.
Outcome during follow up
Mean FU after 12 ± 6.1 months was 95% complete; 9
patients were lost. During FU, mortality was higher in
octogenarians (16.7% versus 6.1%, p = 0.065). Causes of
late death were cardiac in 3 and 1, non-cardiac in 6 and 2,
and unknown in either 1 younger and older patients,
respectively. In neither group, thrombembolic complica-
tions occurred. Compared to discharge, there was a trend
to higher SR conversion rate after 6 and 12 months (Figure
1). Neither between cohorts, nor at different FU visits, sta-
tistical significance was reached. Results regarding rhythm
outcome are outlined in Table 4. At latest available FU, 14
octogenarians (82%) and 101 younger patients (68%, p =
0.231) were in sinus rhythm (SR); 59% without
antiarrhythmic drugs in either group (p = 0.997). Recur-
rent tachyarrhythmia was successfully treated by DC
shock cardioversion in 3 patients aged < 80 years and 1
patient ≥ 80 years and by interventional ablation in 2
younger patients. The majority of patients in SR presented
normal atrial contraction (Table 4). Compared to patients
who were not in SR, patients with restored SR at FU pre-
sented smaller LA size (41 ± 5.3 versus 45 ± 7.3 mm, p =
0.005 and 41 ± 8.8 versus 46 ± 11.6 mm, p = 0.498) and
better NYHA functional class (1.8 ± 0.60 versus 2.2 ± 0.56,
p < 0.001 and 1.9 ± 0.48 versus 2.3 ± 0.58, p = 0.203) in
younger and older age group, respectively. According to
LVEF, left ventricular function remained unchanged in
either group. Kaplan-Meier estimates of freedom from
persistent AF demonstrated no difference between both
groups (Figure 2).
Discussion
A constant extension of life expectancy in industrialized
countries together with an increased incidence of cardio-
vascular disease is leading to a rising number of elderly
patients referred for cardiac surgery. These patients fre-
quently present with AF, because the prevalence of this
arrhythmia is exponentially age-related [6]. Whereas AF
Table 3: Perioperative data
Age < 80 yrs (n = 172) Age ≥ 80 yrs (n = 28) p
betablocker % (n) 27.9 (48) 17.8 (5) 0.172
class III antiarrhythmic drugs % (n) 52.3 (90) 60.7 (17) 0.409
Sotalol % (n) 76.7 (69) 58.8 (10) 0.125
Amiodaron % (n) 23.3 (21) 41.2 (7) 0.125
DC shock cardioversion % (n) 4.6 (8) 3.6 (1) 0.798
pacemaker implantation % (n) 3.5 (6) - -
re-exploration for bleeding % (n) 2.3 (4) - -
pericardial effusion % (n) 1.2 (2) - -
heart failure % (n) 4.1 (7) 7.1 (2) 0.467
inotropic support % (n) 4.1 (7) 7.1 (2) 0.467
IABP % (n) 2.9 (5) 5.1 (4) 0.045
LVAD % (n) 1.2 (2) - -
pulmonary failure % (n) - 3.6 (1) -
renal failure % (n) 7.0 (12) 17.8 (5) 0.056
cerebrovascular accident % (n) 1.7 (3) 3.6 (1) 0.522
intracerebral hemorrhage % (n) 0.6 (1) - -
infection % (n) 4.6 (8) 10.7 (3) 0.192
mediastinitis % (n) 0.6 (1) 3.6 (1) 0.140
bronchopulmonary infection % (n) 4.1 (7) 7.1 (2) 0.467
sepsis % (n) 2.3 (4) 10.7 (3) 0.025
mechanical ventilation time hrs 21 ± 50.3 28 ± 41.1 0.069
ICU stay days 4 ± 7.2 8 ± 16.9 0.027
hospital stay days 14 ± 30.8 20 ± 23.9 0.004
mortality (30 days) % (n) 4.6 (8) 14.3 (4) 0.046
cardiac death % (n) 0.6 (1) 3.6 (1) 0.140
non-cardiac death % (n) 4.1 (7) 10.7 (3) 0.135
DC, direct current; IABP, intraaortic balloon pump; ICU, intensive care unit; LVAD, left ventricular assist device; yrs, yearsJournal of Cardiothoracic Surgery 2008, 3:21 http://www.cardiothoracicsurgery.org/content/3/1/21
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occurs in less than 0.5% of patients younger than 60 years,
approximately 10% of patients older than 80 years are in
AF [6]. Because promising results have been reported on
valvular and coronary surgery in octogenarians [2-4], we
evaluated the outcome of patients in this age group after
concomitant AF ablation.
In this study, octogenarians were different from younger
controls in that they were more likely to be female and
require aortic valve replacement. Either distribution refers
to demographic characteristics and is consistent with pre-
vious reports [15,16]. On the other hand, the underlying
heart disease does not determine results of AF ablation
[7]. The observed inferior functional status according to
NYHA class and the trend to higher incidence of preoper-
ative thrombembolic events may reflect general findings
in advanced age [2]. As age is one of the most important
predictors for operative mortality [14], patients ≥ 80 years
exhibited a significantly higher risk reflected by Euro-
SCORE. According to recent reports, early mortality after
cardiac surgery in octogenarians ranges from 7.5% to
26.5% (table 5). Apart from age, NYHA functional class
[3,17,18], presence of heart failure as well as left ventricu-
lar dysfunction [3,15], pulmonary hypertension [17], and
renal insufficiency [3,19] were demonstrated to be predic-
tive factors for mortality. Furthermore, procedural factors
as urgent/emergency and re-do surgery [3,4,18-20] or
combined valvular plus revascularization surgery [4]
increase operative risk. In this study, patients ≥ 80 years
Kaplan-Meier estimates Figure 2
Kaplan-Meier estimates. Freedom from persistent AF in 
patients </≥ 80 years. AF, atrial fibrillation; yrs, years.
Sinus rhythm at follow up Figure 1
Sinus rhythm at follow up. Figures in bars indicate abso-













Age <80 yrs Age 80 yrs
Table 4: Outcome at last follow up
Age < 80 yrs (n = 148) Age ≥ 80 yrs (n = 17) p
sinus rhythm % (n) 68.2 (101) 82.3 (14) 0.231
atrial contraction % (n) 87.8 (79) 100 (12) 0.200
E/A ratio 2.5 ± 0.83 2.1 ± 0.75 0.179
atrial fibrillation % (n) 26.3 (39) 11.8 (2) 0.187
atrial flutter % (n) 3.4 (5) 5.9 (1) 0.601
NYHA class 1.9 ± 0.61* 2.1 ± 0.57* 0.304
LA diameter mm 42 ± 6.3* 42 ± 9.1* 0.952
LVEF 0.52 ± 0.120† 0.55 ± 0.091* 0.358
LVEDD mm 54 ± 9.4† 49 ± 8.3† 0.048
*p < 0.001, comparison to preoperative data by Wilcoxon rank-sum test
†p = n.s., comparison to preoperative data by Wilcoxon rank-sum test
E/A ratio, ratio of maximal flow velocities of early (E) and atrial (A) diastolic transmitral flow signal assessed by pulsed-wave Doppler; NYHA, New 
York Heart Association; LA, left atrial; LVEF, left ventricular ejection fraction; LVEDD, left ventricular enddiastolic diameter
Assessment of LA function by pulsed wave Doppler failed in 11 and 2 patients in the younger and older age group, respectively.Journal of Cardiothoracic Surgery 2008, 3:21 http://www.cardiothoracicsurgery.org/content/3/1/21
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who died early after operation were characterized by LVEF
≤ 0.40 (n = 2), re-do surgery (n = 1), and other than iso-
lated CABG (n = 4) resulting in a mean logistic Euro-
SCORE of 25.6%. Interestingly, causes of death were
mainly non-cardiac. As reported very recently, AF per se
seems to be a marker for higher operative risk [21,22].
However, the particular impact of AF ablation on periop-
erative mortality has not been clarified, yet. Analysis of
overall complications early after operation (table 3)
reflects the fragility of octogenarians due to age-related
alterations in different organ systems. As in our patients
for instance, renal failure frequently occurs after cardiac
surgery in octogenarians [2,19] and contributes to opera-
tive risk [20]. In contrast to others [2,19,20], we did not
observe an increase in postoperative stroke in our small
cohort of patients. With respect to mechanical ventilation
time, length of ICU and hospital stay, and incidence of
postoperative complications, increased resource utiliza-
tion has to be considered in octogenarians undergoing
cardiac surgery [2].
Overall survival of 82% after mean FU of 12 months was
comparable with outcome after isolated or combined aor-
tic valve replacement (table 5) [20,23]. As AF prevalence
is high in patients older than 80 years [6], it seems obvi-
ous that advanced age predicted recurrent AF after the Cox
Maze procedure in mitral valve disease [24]. Nonetheless,
we found, that SR can be restored in the majority of eld-
erly patients leading to normal atrial contraction and
symptomatic improvement regarding NYHA functional
class. Although octogenarians more frequently presented
with paroxysmal AF at baseline, 71.4% of patients ≥ 80
years with persistent AF before operation were in SR at last
FU. Moreover, freedom from AF during FU was not differ-
ent in octogenarians and younger patients (figure 2). The
overall SR conversion rate observed in this study is within
the range of 57–92%, reported in a recent metaanalysis
[25]. At least in part, this could be attributed to the left
atrial in contrast to the classical biatrial approach. How-
ever, a less complex procedure for concomitant AF treat-
ment might be beneficial, in particular for octogenarians.
Furthermore, it was shown that AF will not recur if macro-
reentry can be prevented by lesions critically placed in the
left atrium [11,13].
Conclusion
This is the first report on concomitant AF ablation in octo-
genarians undergoing cardiac surgery. The main finding
is, that SR and atrial transport function could be restored
in the majority of patients. Certainly, ongoing research
has to prove these results in larger cohorts and during
long-term follow up. Because this study is a retrospective
analysis of prospectively collected data it suffers from gen-
eral limitations inherent to observational studies in non-
randomized patient groups. Hence, we are unable to gen-
eralize our results to all patients ≥ 80 years with AF neces-
sitating cardiac surgery. Preoperative identification of
candidates in whom concomitant AF ablation will
improve outcome is indeed challenging, especially if peri-
operative risk and a certain percentage of patients remain-
ing in AF are considered. Nevertheless, our finding
suggests integration of concomitant AF ablation as reason-
able treatment strategy in elderly patients with AF referred
for cardiac surgery.
List of abbreviations used
AAR: ascending aortic replacement; AF: atrial fibrillation;
AVR: aortic valve replacement; CABG: coronary artery
bypass grafting; DC: direct current; ECG: electrocardio-
gram; FU: follow up; IABP: intraaortic balloon pump;
ICU: intensive care unit; INR: international normalized
ratio; LA: left atrial; LV: left ventricular; LVAD: left ven-
Table 5: Outcome of octogenarians undergoing cardiac surgery
procedure author year n operative mortality longterm survival
1 year 5 years
CABG isolated Alexander [19] 2000 4306 8.1% (hospital) - -
isolated Kolh [18] 2001 70 10.0% (hospital) - 65.8%
isolated Scott [2] 2005 155 9.0% (30 days) - -
AVR combined Alexander [19] 2000 345 10.1% (hospital) - -
isolated and combined Sundt [20] 2000 133 11.0% (30 days) 80.0% 55.0%
isolated Kolh [18] 2001 70 8.5% (hospital) - 63.6%
combined Kolh [18] 2001 30 26.5% (hospital) - 62.4%
isolated and combined Chiappini [23] 2004 115 8.5% (hospital) 86.4% 69.4%
isolated and combined Langanay [3] 2006 442 7.5% - -
MVP-/R combined Alexander [19] 2000 92 19.7% (hospital) - -
isolated Kolh [18] 2001 12 25.0% (hospital) 57.1%
isolated and combined Nagendran [4] 2005 58 15.5% (hospital) - 70.0%
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tricular assist device; LVEDD: left ventricular enddiastolic
diameter; LVEF: left ventricular ejection fraction; MVP/-R:
mitral valve plasty/replacement; n.s., not significant;
NYHA: New York Heart Association; POD: postoperative
day; SR: sinus rhythm; TTE: transthoracic echocardiogra-
phy; TVP/R: tricuspid valve plasty/replacement; Yrs, years
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